CASR and Parkinson disease: Degenerative diseases of the brain such as Parkinson’s and Alzheimer’s disease may also be affected by both glutathionergics [85,86,87] and CaSR [88,89,90,91] in brain tissue; however, their neural and systemic interactions are complex and beyond the scope of the present review.